Profiel
Gregor Lichtfuss was the founder of Ribosomic Pty Ltd.
founded in 2016 and Exopharm Ltd.
founded in 2013 where he held the title of Chief Operating Officer from 2013 to 2023.
He has a doctorate from Monash University and a graduate degree from Humboldt-Universität zu Berlin.
Eerdere bekende functies van Gregor Lichtfuss
| Bedrijven | Functie | Einde |
|---|---|---|
| EXOPHARM | Founder | 28-11-2023 |
| Ribosomic Pty Ltd. | Founder | - |
Opleiding van Gregor Lichtfuss
| Monash University | Doctorate Degree |
| Humboldt-Universität zu Berlin | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Exopharm Ltd.
 Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Exopharm Ltd. engages in the research and development of biopharmaceutical drugs. The company was founded by Ian Dixon and Gregor Lichtfuss in 2013 and is headquartered in Camberwell, Australia. | Health Technology |
| Ribosomic Pty Ltd. |
